Navigation Links
Tone Deafness Explained, from the Harvard Health Letter
Date:8/23/2007

BOSTON, Aug. 23 /PRNewswire-USNewswire/ -- Do people cringe when you sing? You've got company. But researchers have found that only 1 in 20 people truly has amusia, the technical term for tone deafness. Tests have shown that some people with bad singing voices hear music just fine. Amusics are a smaller group with a perceptual problem: They can't pick out differences in pitch or follow the simplest tunes, reports the September 2007 issue of the Harvard Health Letter.

Brain scans haven't revealed major anatomical differences in amusics, but more sophisticated tests have uncovered some subtle variations. In a study comparing amusics to people with normal musical ability, researchers used a brain imaging and statistical technique to measure the density of the white matter (which consists of connecting nerve fibers) between the right frontal lobe, where higher thinking occurs, and the right temporal lobes, where basic processing of sound occurs. The white matter of the amusics was thinner, which suggests a weaker connection. Moreover, the worse the tone deafness, the thinner the white matter.

Some experts believe there's a great deal of overlap between how the brain handles music and how it handles speech, which also has elements of pitch and rhythm. Others, though, believe that musical perception and thinking occur separately from other functions, and that our brains are predisposed toward developing centers and networks dedicated exclusively to music.

If you want to test your ability to perceive music, the Harvard Health Letter refers readers to an online test at http://www.delosis.com/listening developed by researchers at the University of Newcastle-upon-Tyne in England.

Also in this issue:

-- Benefits of unsaturated fat

-- New types of lenses for cataract surgery

-- Thyroid hormone not a good means for weight loss

-- By the way doctor: Quitting smoking and getting a cough; cellulitis

explained.

The Harvard Health Letter is available from Harvard Health Publications, the publishing division of Harvard Medical School, for $28 per year. Subscribe at http://www.health.harvard.edu/health or by calling 1-877-649-9457 (toll free).

Media: Contact Christine Junge at Christine_Junge@hms.harvard.edu for a complimentary copy of the newsletter, or to receive our press releases directly.


'/>"/>
SOURCE Harvard Health Letter
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
2. Bipolar Disorder in Children Difficult to Diagnose, Reports the Harvard Mental Health Letter
3. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
4. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
5. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. Data Showing that ReGens Colostrinin Supports Healthy Cognitive Function Presented at the 2007 International Congress on Natural Medicine in Australia
8. FDLI 50th Annual Meeting Heralds New ERA in Healthcare Innovations, FDA Regulations
9. New Data On the Probiotic Strain Bifantis Shows Anti-Inflammatory Properties and Increased Health Benefits
10. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
11. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... Calif. , June 9, 2017 AirXpanders, ... company focused on the design, manufacture, sale and distribution ... market on the progress of its commercial roll-out in ... now available in more than one hundred (100) medical ... AeroForm offers a needle-free alternative for women ...
(Date:6/7/2017)... Endo International plc (NASDAQ: ENDP ... Joseph R. Goodwin , U.S. District Court Judge ... , entered a case management order in MDL ... Liability Litigation (the "MDL") that includes a provision requiring ... disclosures on specific causation within one hundred twenty (120) ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... 28, 2017 , ... Guide to FDA and EU Medical Device Regulations: 2017 ... side of the Atlantic devicemakers do business, this fully updated and expanded guide keeps ... addition to the full text of the FDA’s regulations in 21 CFR Parts 800 ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... David B. Sosin, a founding ... Illinois, took over the post of 2nd Vice President for the Illinois State Bar ... installed as the ISBA’s 3rd Vice President in 2016 following a state-wide election and served ...
(Date:6/28/2017)... Columbia (PRWEB) , ... June 28, 2017 , ... ... (FSE: ZEON) is pleased to announce that a two year study conducted by ... Company's Bromley Creek zeolite was successful in remediating potash brine-impacted groundwater. As a ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... ... 2017 , ... Harbour , a DAO (decentralized autonomous organization) that harnesses ... released their technical specifications . , 2017 has seen an explosion of token ... determining which offerings will garner the greatest ROI. Dean Eigenmann, Co-founder and CEO of ...
Breaking Medicine News(10 mins):